E-LIB Suche - Ergebnisse für: Pignata, I

1

Cannabis for Medical Use: Analysis of Recent Clinical Trial..:

Baratta, F. ; Pignata, I. ; Ravetto Enri, L..
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

2

Oncological patient management on the territory: the result..:

Baratta F ; Pignata I ; Vicenzi G...
info:eu-repo/semantics/altIdentifier/wos/WOS:000893130700001. , 2022

Link: https://hdl.handle.net/2..

3

Cannabis for Medical Use: Analysis of Recent Clinical Trial..:

Baratta, F ; Pignata, I ; Ravetto Enri, L.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174563/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Cannabis for Medical Use: Analysis of Recent Clinical Trial..:

Baratta, F ; Pignata, I ; Ravetto Enri, L.
info:eu-repo/semantics/altIdentifier/pmid/35694246. , 2022

Link: http://hdl.handle.net/23..

5

Farmacisti: una popolazione particolarmente esposta?:

Parente M ; Baratta F ; Visentin GM...
ispartofbook:-. , 2020

Link: http://hdl.handle.net/23..

6

Assessment of Non-Adherence to Oral Metformin and Atorvasta..:

Parente M ; Pignata I ; Gnavi R...
https://www.dovepress.com/assessment-of-non-adherence-to-oral-metformin-and-atorvastatin-therapi-peer-reviewed-article-PPA. , 2020

Link: https://doaj.org/article..

7

Dalla parte dei clienti: cos'è cambiato in farmacia durante..:

Baratta F ; Ciccolella M ; Visentin GM...
ispartofbook:/. , 2020

Link: http://hdl.handle.net/23..

8

Assessment of non-adherence to oral metformin and atorvasta..:

Parente M ; Pignata I ; Gnavi R...
info:eu-repo/semantics/altIdentifier/pmid/32103910. , 2020

Link: http://hdl.handle.net/23..

9

How to promote vaccinations: a pilot study in the North-Wes..:

Ravetto Enri L ; Baratta F ; Pignata I.
info:eu-repo/semantics/altIdentifier/pmid/30779685. , 2019

Link: http://hdl.handle.net/23..

10

A kilonova as the electromagnetic counterpart to a gravitat..:

Smartt, S. J ; Chen, T. -W ; Jerkstrand, A...
NATURE. , 2017

Link: https://hdl.handle.net/2..

11

Cannabis for Medical Use: Analysis of Recent Clinical Trial..:

F. Baratta ; I. Pignata ; L. Ravetto Enri.
https://www.frontiersin.org/articles/10.3389/fphar.2022.888903/full. , 2022

Link: https://doi.org/10.3389/..

12

39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembr..:

Pignata, S. ; Marth, C. ; Moore, R.G....
ESMO Open. 9 (2024) - p. 103539 , 2024

Link: https://doi.org/10.1016/..

13

47MO The risk index of early relapse defined by MiROvaR, a ..:

Bagnoli, M. ; De Cecco, L. ; Califano, D....
ESMO Open. 9 (2024) - p. 103554 , 2024

Link: https://doi.org/10.1016/..

14

45P MITO39: Effiacy and tolerability of PLD-trabectedin in ..:

Turinetto, M. ; Pignata, S. ; Pisano, C....
ESMO Open. 8 (2023) 1 - p. 100825 , 2023

Link: https://doi.org/10.1016/..

15

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carb..:

Vergote, I. ; Van Nieuwenhuysen, E. ; Casado, A....
Gynecologic Oncology. 174 (2023) - p. 80-88 , 2023

Link: https://doi.org/10.1016/..